Deka Bank Deutsche Girozentrale Avrobio, Inc. Transaction History

Deka Bank Deutsche Girozentrale

  • $54.1 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 02, 2022
SELL
$3.45 - $6.05 $244,950 - $429,550
-71,000 Closed
0 $0
Q2 2021

Aug 05, 2021
SELL
$7.84 - $12.6 $548,800 - $882,000
-70,000 Reduced 49.65%
71,000 $638,000
Q1 2021

Apr 28, 2021
BUY
$10.54 - $19.3 $1.32 Million - $2.41 Million
125,000 Added 781.25%
141,000 $1.68 Million
Q3 2020

Oct 29, 2020
BUY
$12.99 - $19.41 $207,840 - $310,560
16,000 New
16,000 $213,000

Others Institutions Holding AVRO

# of Institutions
1
Shares Held
559K
Call Options Held
0
Put Options Held
0
View Full List

About AVROBIO, Inc.

AVRO Quotes by TradingView
  • Ticker AVRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,773,900
  • Description
  • AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...
More about AVRO
Track This Portfolio

Track Deka Bank Deutsche Girozentrale Portfolio

Follow Deka Bank Deutsche Girozentrale and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email